Halae, Analyn .

HRN: 22-82-50  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2023
CEFTRIAXONE 1G (VIAL)
04/07/2023
04/13/2023
IV
2g
OD
UTI
Waiting Final Action 
04/07/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/07/2023
04/13/2023
IV
500 Mg
Q8
Bacterial Vaginosis
Waiting Final Action 
04/07/2023
CEFUROXIME 500MG (TAB)
04/07/2023
04/14/2023
PO
500 Mg
Every 12 Hours
UTI
Waiting Final Action 
04/07/2023
METRONIDAZOLE 500MG (TAB)
04/07/2023
04/14/2023
PO
500 Mg
Every 12 Hours
Bacterial Vaginosis
Waiting Final Action 
09/10/2023
CEFUROXIME 500MG (TAB)
09/10/2023
09/16/2023
PO
500
BID
Nsvd
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: